Clinical Trials Logo

Stage III Rectal Cancer AJCC v8 clinical trials

View clinical trials related to Stage III Rectal Cancer AJCC v8.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT04751370 Suspended - Clinical trials for Stage III Rectal Cancer AJCC v8

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer

Start date: February 8, 2022
Phase: Phase 2
Study type: Interventional

This phase II trial investigates the effect of nivolumab and ipilimumab when given together with short-course radiation therapy in treating patients with rectal cancer that has spread to nearby tissue or lymph nodes (locally advanced). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving nivolumab, ipilimumab, and radiation therapy may kill more cancer cells.